Improving Treatment Adherence in HIV-Infected Individuals
Changing ART Adherence Behavior: The Lifewindows Project
Sponsor: National Institute of Mental Health (NIMH)
This PHASE2 trial investigates HIV Antiretroviral Therapy (ART) Adherence and Health Behavior and is currently completed. National Institute of Mental Health (NIMH) leads this study, which shows 9 recorded versions since 2005 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Completed PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 4 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed PHASE2
-
May 2018 — Jun 2018 [monthly]
Completed PHASE2
-
Aug 2017 — May 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Aug 2017 [monthly]
Completed PHASE2
First recorded
Oct 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Mental Health (NIMH)
- University of Connecticut
For direct contact, visit the study record on ClinicalTrials.gov .